Response to Comment on: “HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial”

Nathalie Dhédin; Corinne Pondarre

doi:10.3324/haematol.2026.301445

Comments

Response to Comment on: “HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial”

Nathalie Dhédin
Corinne Pondarre

Adolescent and Young Adult Hematology Unit, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Epidemiology and Clinical Statistics for Trials & Real-world evidence Research (ECSTRRA), Saint Louis Research Institute, UMR1342, INSERM, Université de Paris

Intercommunal Hospital Center of Créteil, INSERM U955, IMRB, Paris XII University, Créteil

Haematologica Early view Jul 30, 2026 https://doi.org/10.3324/haematol.2026.301445

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments

DOI

https://doi.org/10.3324/haematol.2026.301445

Published

2026-07-30

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

Copyright & Usage

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

14

PDF Downloads

3

No Data

PlumX

Response to Comment on: “HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial”

Abstract

Figures & Tables

Article Information

Article Usage

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More